Entera Bio Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +128.8% | +111.2% | +0.5% | +25.2% | -41.8% | +167.3% | -49.5% | -10.4% | -20.2% | +70.3% | |
| – | +185.9% | +128.5% | +0.4% | +25.4% | -41.7% | +178.1% | -49.3% | -12.4% | -20.3% | -20.8% | |
| – | +245.5% | +182.2% | -36.1% | +102.8% | -43.5% | +189.7% | -50.6% | -10.5% | -21.4% | -17.9% | |
| – | +245.5% | +182.2% | -1.9% | +32.1% | -43.5% | +189.7% | -50.6% | -10.5% | -21.4% | -17.9% | |
| – | – | – | – | -61.7% | -8.3% | -28.2% | +34.4% | -100.0% | – | +73.8% | |
| – | – | – | – | -41.5% | -222.4% | – | – | – | – | – | |
| – | +3.1% | +4.0% | +8.2% | +106.3% | +18.6% | -27.9% | -42.0% | – | – | – | |
| – | +0.0% | +0.0% | -0.5% | -7.1% | +0.0% | – | – | – | – | – | |
| – | +10.9% | +42.2% | -92.8% | +48.3% | -53.8% | +54.7% | -59.9% | +0.4% | -5.0% | +120.8% | |
| – | +1,211.2% | -80.8% | -11.5% | +156.8% | -59.9% | +71.7% | -57.6% | -18.6% | +7.8% | +87.3% | |
| – | -53.2% | +277.8% | – | – | +6.8% | -5.3% | -49.2% | +47.3% | +26.9% | +35.3% | |
| – | -84.9% | +1,024.5% | -20.6% | -29.4% | -50.9% | +1.2% | -89.8% | +388.2% | +59.0% | +239.4% | |
| – | -77.1% | -19.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | +17.8% | -37.0% | +200.5% | -47.9% | -11.6% | -22.2% | +62.1% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -3.3% | +5.5% | +51.6% | +41.9% | +10.2% | +0.7% | +29.8% | +22.7% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.